All In MedTech

Device Trial Radar · NCT04341246

Characterization and Technical Evaluation of cT1 for NASH (CATE-NASH)

Characterization and Technical Evaluation of cT1 for NASH (CATE-NASH): A Case-control Study

Last checked: Nov 19, 2026Latest source record: Jan 3, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

28

Actual

Start

Jan 28, 2021

Primary completion

Jun 12, 2023

Study completion Jun 12, 2023

Sponsor

Lead sponsor
PerspectumNot on our public-company list
Sponsor type
Industry
Collaborators
Food and Drug Administration (FDA)
First posted
Apr 10, 2020

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this study is to evaluate to provide evidence to establish tightly defined cut-offs to identify patients for NASH clinical trial inclusion using cT1 and/or PDFF. The study will be divided into 2 sub groups comprising of cases and controls.

Conditions

  • Non-Alcoholic Fatty Liver Disease

Interventions

  • LiverMultiscanDevice

    The Livermultiscan is a quick, 15 minute contrast free MRI scan that provided metrics to quantify liver health namely fat, iron and fibro-inflammation

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To demonstrate that a binary decision algorithm applied to cT1 can significantly identify patients whose liver biopsy results would qualify them for randomization in a clinical trial testing an investigational treatment for NASHTime frame: 6 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Massachusetts General Hospital

    Boston, Massachusetts

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.